Pharmacodynamic target attainment of six β‐lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and …

CA DeRyke, JL Kuti, DP Nicolau - … : The Journal of Human …, 2007 - Wiley Online Library
Study Objective. To determine the likelihood that antibiotic regimens achieve bactericidal
pharmacodynamic exposures against common nosocomial pathogens. Design …

Pharmacodynamic target attainment of six β-lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and …

CA DeRyke, LK Joseph, PN David - 2007 - cabidigitallibrary.org
Abstract Study Objective. To determine the likelihood that antibiotic regimens achieve
bactericidal pharmacodynamic exposures against common nosocomial pathogens. Design …

Pharmacodynamic target attainment of six beta-lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and …

CA DeRyke, JL Kuti, DP Nicolau - Pharmacotherapy, 2007 - pubmed.ncbi.nlm.nih.gov
Study objective To determine the likelihood that antibiotic regimens achieve bactericidal
pharmacodynamic exposures against common nosocomial pathogens. Design …

[引用][C] Pharmacodynamic target attainment of six β-Lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli …

CA DERYKE, JL KUTI, DP NICOLAU - Pharmacotherapy, 2007 - pascal-francis.inist.fr
Pharmacodynamic target attainment of six β-Lactams and two fluoroquinolones against
Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Klebsiella species …

Pharmacodynamic target attainment of six beta-lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and …

CA DeRyke, JL Kuti, DP Nicolau - Pharmacotherapy, 2007 - europepmc.org
Pharmacodynamic target attainment of six beta-lactams and two fluoroquinolones against
Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Klebsiella species …

[引用][C] Pharmacodynamic target attainment of six β-Lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli …

CA DERYKE, JL KUTI, DP NICOLAU - Pharmacotherapy, 2007 - Pharmacotherapy